Global Synthetic Lethality-based Drugs and Targets Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Synthetic Lethality-based Drugs and Targets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Synthetic Lethality-based Drugs and Targets market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Medical Research Institution accounting for % of the Synthetic Lethality-based Drugs and Targets global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monotherapy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Synthetic Lethality-based Drugs and Targets include AbbVie, AstraZeneca, BeiGene, Clovis Oncology, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Synthetic Lethality-based Drugs and Targets market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Synthetic Lethality-based Drugs and Targets product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Synthetic Lethality-based Drugs and Targets, with revenue, gross margin and global market share of Synthetic Lethality-based Drugs and Targets from 2019 to 2022.
Chapter 3, the Synthetic Lethality-based Drugs and Targets competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Synthetic Lethality-based Drugs and Targets market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Synthetic Lethality-based Drugs and Targets research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Synthetic Lethality-based Drugs and Targets market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Medical Research Institution accounting for % of the Synthetic Lethality-based Drugs and Targets global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monotherapy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Synthetic Lethality-based Drugs and Targets include AbbVie, AstraZeneca, BeiGene, Clovis Oncology, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Synthetic Lethality-based Drugs and Targets market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Monotherapy
- Combination Therapy
- Medical Research Institution
- Hospital and Clinic
- Other
- AbbVie
- AstraZeneca
- BeiGene
- Clovis Oncology
- GlaxoSmithKline
- Pfizer
- AtlasMedx
- Chordia Therapeutics
- IDEAYA Biosciences
- Mission Therapeutics
- Repare Therapeutics
- Sierra Oncology
- SyntheX Labs
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Synthetic Lethality-based Drugs and Targets product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Synthetic Lethality-based Drugs and Targets, with revenue, gross margin and global market share of Synthetic Lethality-based Drugs and Targets from 2019 to 2022.
Chapter 3, the Synthetic Lethality-based Drugs and Targets competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Synthetic Lethality-based Drugs and Targets market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Synthetic Lethality-based Drugs and Targets research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Synthetic Lethality-based Drugs and Targets
1.2 Classification of Synthetic Lethality-based Drugs and Targets by Type
1.2.1 Overview: Global Synthetic Lethality-based Drugs and Targets Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type in 2021
1.2.3 Monotherapy
1.2.4 Combination Therapy
1.3 Global Synthetic Lethality-based Drugs and Targets Market by Application
1.3.1 Overview: Global Synthetic Lethality-based Drugs and Targets Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Global Synthetic Lethality-based Drugs and Targets Market Size & Forecast
1.5 Global Synthetic Lethality-based Drugs and Targets Market Size and Forecast by Region
1.5.1 Global Synthetic Lethality-based Drugs and Targets Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Synthetic Lethality-based Drugs and Targets Market Size by Region, (2017-2022)
1.5.3 North America Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.5.4 Europe Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.5.6 South America Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Synthetic Lethality-based Drugs and Targets Market Drivers
1.6.2 Synthetic Lethality-based Drugs and Targets Market Restraints
1.6.3 Synthetic Lethality-based Drugs and Targets Trends Analysis
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Product and Solutions
2.1.4 AbbVie Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Product and Solutions
2.2.4 AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 BeiGene
2.3.1 BeiGene Details
2.3.2 BeiGene Major Business
2.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Product and Solutions
2.3.4 BeiGene Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 BeiGene Recent Developments and Future Plans
2.4 Clovis Oncology
2.4.1 Clovis Oncology Details
2.4.2 Clovis Oncology Major Business
2.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Product and Solutions
2.4.4 Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Clovis Oncology Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product and Solutions
2.5.4 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Product and Solutions
2.6.4 Pfizer Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 AtlasMedx
2.7.1 AtlasMedx Details
2.7.2 AtlasMedx Major Business
2.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Product and Solutions
2.7.4 AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 AtlasMedx Recent Developments and Future Plans
2.8 Chordia Therapeutics
2.8.1 Chordia Therapeutics Details
2.8.2 Chordia Therapeutics Major Business
2.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
2.8.4 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Chordia Therapeutics Recent Developments and Future Plans
2.9 IDEAYA Biosciences
2.9.1 IDEAYA Biosciences Details
2.9.2 IDEAYA Biosciences Major Business
2.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product and Solutions
2.9.4 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 IDEAYA Biosciences Recent Developments and Future Plans
2.10 Mission Therapeutics
2.10.1 Mission Therapeutics Details
2.10.2 Mission Therapeutics Major Business
2.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
2.10.4 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Mission Therapeutics Recent Developments and Future Plans
2.11 Repare Therapeutics
2.11.1 Repare Therapeutics Details
2.11.2 Repare Therapeutics Major Business
2.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
2.11.4 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Repare Therapeutics Recent Developments and Future Plans
2.12 Sierra Oncology
2.12.1 Sierra Oncology Details
2.12.2 Sierra Oncology Major Business
2.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Product and Solutions
2.12.4 Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Sierra Oncology Recent Developments and Future Plans
2.13 SyntheX Labs
2.13.1 SyntheX Labs Details
2.13.2 SyntheX Labs Major Business
2.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Product and Solutions
2.13.4 SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 SyntheX Labs Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Synthetic Lethality-based Drugs and Targets Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Synthetic Lethality-based Drugs and Targets Players Market Share in 2021
3.2.2 Top 10 Synthetic Lethality-based Drugs and Targets Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Synthetic Lethality-based Drugs and Targets Players Head Office, Products and Services Provided
3.4 Synthetic Lethality-based Drugs and Targets Mergers & Acquisitions
3.5 Synthetic Lethality-based Drugs and Targets New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Synthetic Lethality-based Drugs and Targets Revenue and Market Share by Type (2017-2022)
4.2 Global Synthetic Lethality-based Drugs and Targets Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2017-2022)
5.2 Global Synthetic Lethality-based Drugs and Targets Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
6.2 North America Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Country
6.3.1 North America Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2028)
6.3.2 United States Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
6.3.3 Canada Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
6.3.4 Mexico Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
7.2 Europe Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country
7.3.1 Europe Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2028)
7.3.2 Germany Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7.3.3 France Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7.3.5 Russia Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7.3.6 Italy Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region
8.3.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Region (2017-2028)
8.3.2 China Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.3 Japan Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.4 South Korea Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.5 India Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.7 Australia Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
9.2 South America Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
9.3 South America Synthetic Lethality-based Drugs and Targets Market Size by Country
9.3.1 South America Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2028)
9.3.2 Brazil Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
9.3.3 Argentina Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country
10.3.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2028)
10.3.2 Turkey Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
10.3.4 UAE Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Synthetic Lethality-based Drugs and Targets
1.2 Classification of Synthetic Lethality-based Drugs and Targets by Type
1.2.1 Overview: Global Synthetic Lethality-based Drugs and Targets Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type in 2021
1.2.3 Monotherapy
1.2.4 Combination Therapy
1.3 Global Synthetic Lethality-based Drugs and Targets Market by Application
1.3.1 Overview: Global Synthetic Lethality-based Drugs and Targets Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Global Synthetic Lethality-based Drugs and Targets Market Size & Forecast
1.5 Global Synthetic Lethality-based Drugs and Targets Market Size and Forecast by Region
1.5.1 Global Synthetic Lethality-based Drugs and Targets Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Synthetic Lethality-based Drugs and Targets Market Size by Region, (2017-2022)
1.5.3 North America Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.5.4 Europe Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.5.6 South America Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Synthetic Lethality-based Drugs and Targets Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Synthetic Lethality-based Drugs and Targets Market Drivers
1.6.2 Synthetic Lethality-based Drugs and Targets Market Restraints
1.6.3 Synthetic Lethality-based Drugs and Targets Trends Analysis
2 COMPANY PROFILES
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Product and Solutions
2.1.4 AbbVie Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Product and Solutions
2.2.4 AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 BeiGene
2.3.1 BeiGene Details
2.3.2 BeiGene Major Business
2.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Product and Solutions
2.3.4 BeiGene Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 BeiGene Recent Developments and Future Plans
2.4 Clovis Oncology
2.4.1 Clovis Oncology Details
2.4.2 Clovis Oncology Major Business
2.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Product and Solutions
2.4.4 Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Clovis Oncology Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product and Solutions
2.5.4 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Product and Solutions
2.6.4 Pfizer Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 AtlasMedx
2.7.1 AtlasMedx Details
2.7.2 AtlasMedx Major Business
2.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Product and Solutions
2.7.4 AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 AtlasMedx Recent Developments and Future Plans
2.8 Chordia Therapeutics
2.8.1 Chordia Therapeutics Details
2.8.2 Chordia Therapeutics Major Business
2.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
2.8.4 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Chordia Therapeutics Recent Developments and Future Plans
2.9 IDEAYA Biosciences
2.9.1 IDEAYA Biosciences Details
2.9.2 IDEAYA Biosciences Major Business
2.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product and Solutions
2.9.4 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 IDEAYA Biosciences Recent Developments and Future Plans
2.10 Mission Therapeutics
2.10.1 Mission Therapeutics Details
2.10.2 Mission Therapeutics Major Business
2.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
2.10.4 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Mission Therapeutics Recent Developments and Future Plans
2.11 Repare Therapeutics
2.11.1 Repare Therapeutics Details
2.11.2 Repare Therapeutics Major Business
2.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
2.11.4 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Repare Therapeutics Recent Developments and Future Plans
2.12 Sierra Oncology
2.12.1 Sierra Oncology Details
2.12.2 Sierra Oncology Major Business
2.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Product and Solutions
2.12.4 Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Sierra Oncology Recent Developments and Future Plans
2.13 SyntheX Labs
2.13.1 SyntheX Labs Details
2.13.2 SyntheX Labs Major Business
2.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Product and Solutions
2.13.4 SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 SyntheX Labs Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Synthetic Lethality-based Drugs and Targets Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Synthetic Lethality-based Drugs and Targets Players Market Share in 2021
3.2.2 Top 10 Synthetic Lethality-based Drugs and Targets Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Synthetic Lethality-based Drugs and Targets Players Head Office, Products and Services Provided
3.4 Synthetic Lethality-based Drugs and Targets Mergers & Acquisitions
3.5 Synthetic Lethality-based Drugs and Targets New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Synthetic Lethality-based Drugs and Targets Revenue and Market Share by Type (2017-2022)
4.2 Global Synthetic Lethality-based Drugs and Targets Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application (2017-2022)
5.2 Global Synthetic Lethality-based Drugs and Targets Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
6.2 North America Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Country
6.3.1 North America Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2028)
6.3.2 United States Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
6.3.3 Canada Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
6.3.4 Mexico Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
7.2 Europe Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country
7.3.1 Europe Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2028)
7.3.2 Germany Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7.3.3 France Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7.3.5 Russia Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
7.3.6 Italy Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
8.2 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
8.3 Asia-Pacific Synthetic Lethality-based Drugs and Targets Market Size by Region
8.3.1 Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Region (2017-2028)
8.3.2 China Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.3 Japan Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.4 South Korea Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.5 India Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
8.3.7 Australia Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
9.2 South America Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
9.3 South America Synthetic Lethality-based Drugs and Targets Market Size by Country
9.3.1 South America Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2028)
9.3.2 Brazil Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
9.3.3 Argentina Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2028)
10.2 Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2028)
10.3 Middle East & Africa Synthetic Lethality-based Drugs and Targets Market Size by Country
10.3.1 Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2028)
10.3.2 Turkey Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
10.3.4 UAE Synthetic Lethality-based Drugs and Targets Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Synthetic Lethality-based Drugs and Targets Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Synthetic Lethality-based Drugs and Targets Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Synthetic Lethality-based Drugs and Targets Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Synthetic Lethality-based Drugs and Targets Revenue (USD Million) by Region (2017-2022)
Table 5. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Region (2023-2028)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 9. AbbVie Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 13. AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BeiGene Corporate Information, Head Office, and Major Competitors
Table 15. BeiGene Major Business
Table 16. BeiGene Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 17. BeiGene Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Clovis Oncology Corporate Information, Head Office, and Major Competitors
Table 19. Clovis Oncology Major Business
Table 20. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 21. Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 25. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Pfizer Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Major Business
Table 28. Pfizer Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 29. Pfizer Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. AtlasMedx Corporate Information, Head Office, and Major Competitors
Table 31. AtlasMedx Major Business
Table 32. AtlasMedx Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 33. AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Chordia Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. Chordia Therapeutics Major Business
Table 36. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 37. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. IDEAYA Biosciences Corporate Information, Head Office, and Major Competitors
Table 39. IDEAYA Biosciences Major Business
Table 40. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 41. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Mission Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Mission Therapeutics Major Business
Table 44. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 45. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Repare Therapeutics Corporate Information, Head Office, and Major Competitors
Table 47. Repare Therapeutics Major Business
Table 48. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 49. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Sierra Oncology Corporate Information, Head Office, and Major Competitors
Table 51. Sierra Oncology Major Business
Table 52. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 53. Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. SyntheX Labs Corporate Information, Head Office, and Major Competitors
Table 55. SyntheX Labs Major Business
Table 56. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 57. SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Synthetic Lethality-based Drugs and Targets Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Synthetic Lethality-based Drugs and Targets by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Synthetic Lethality-based Drugs and Targets Players Head Office, Products and Services Provided
Table 62. Synthetic Lethality-based Drugs and Targets Mergers & Acquisitions in the Past Five Years
Table 63. Synthetic Lethality-based Drugs and Targets New Entrants and Expansion Plans
Table 64. Global Synthetic Lethality-based Drugs and Targets Revenue (USD Million) by Type (2017-2022)
Table 65. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Type (2017-2022)
Table 66. Global Synthetic Lethality-based Drugs and Targets Revenue Forecast by Type (2023-2028)
Table 67. Global Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022)
Table 68. Global Synthetic Lethality-based Drugs and Targets Revenue Forecast by Application (2023-2028)
Table 69. North America Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Synthetic Lethality-based Drugs and Targets Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Synthetic Lethality-based Drugs and Targets Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Synthetic Lethality-based Drugs and Targets Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Synthetic Lethality-based Drugs and Targets Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Synthetic Lethality-based Drugs and Targets Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Synthetic Lethality-based Drugs and Targets Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Synthetic Lethality-based Drugs and Targets Revenue (USD Million) by Region (2017-2022)
Table 5. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Region (2023-2028)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 9. AbbVie Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 13. AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BeiGene Corporate Information, Head Office, and Major Competitors
Table 15. BeiGene Major Business
Table 16. BeiGene Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 17. BeiGene Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Clovis Oncology Corporate Information, Head Office, and Major Competitors
Table 19. Clovis Oncology Major Business
Table 20. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 21. Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 25. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Pfizer Corporate Information, Head Office, and Major Competitors
Table 27. Pfizer Major Business
Table 28. Pfizer Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 29. Pfizer Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. AtlasMedx Corporate Information, Head Office, and Major Competitors
Table 31. AtlasMedx Major Business
Table 32. AtlasMedx Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 33. AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Chordia Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. Chordia Therapeutics Major Business
Table 36. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 37. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. IDEAYA Biosciences Corporate Information, Head Office, and Major Competitors
Table 39. IDEAYA Biosciences Major Business
Table 40. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 41. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Mission Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Mission Therapeutics Major Business
Table 44. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 45. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Repare Therapeutics Corporate Information, Head Office, and Major Competitors
Table 47. Repare Therapeutics Major Business
Table 48. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 49. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Sierra Oncology Corporate Information, Head Office, and Major Competitors
Table 51. Sierra Oncology Major Business
Table 52. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 53. Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. SyntheX Labs Corporate Information, Head Office, and Major Competitors
Table 55. SyntheX Labs Major Business
Table 56. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product and Solutions
Table 57. SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Synthetic Lethality-based Drugs and Targets Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Synthetic Lethality-based Drugs and Targets by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Synthetic Lethality-based Drugs and Targets Players Head Office, Products and Services Provided
Table 62. Synthetic Lethality-based Drugs and Targets Mergers & Acquisitions in the Past Five Years
Table 63. Synthetic Lethality-based Drugs and Targets New Entrants and Expansion Plans
Table 64. Global Synthetic Lethality-based Drugs and Targets Revenue (USD Million) by Type (2017-2022)
Table 65. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Type (2017-2022)
Table 66. Global Synthetic Lethality-based Drugs and Targets Revenue Forecast by Type (2023-2028)
Table 67. Global Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022)
Table 68. Global Synthetic Lethality-based Drugs and Targets Revenue Forecast by Application (2023-2028)
Table 69. North America Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Synthetic Lethality-based Drugs and Targets Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Synthetic Lethality-based Drugs and Targets Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Synthetic Lethality-based Drugs and Targets Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Synthetic Lethality-based Drugs and Targets Picture
Figure 2. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type in 2021
Figure 3. Monotherapy
Figure 4. Combination Therapy
Figure 5. Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application in 2021
Figure 6. Medical Research Institution Picture
Figure 7. Hospital and Clinic Picture
Figure 8. Other Picture
Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Synthetic Lethality-based Drugs and Targets Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Region (2017-2028)
Figure 12. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Region in 2021
Figure 13. North America Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Synthetic Lethality-based Drugs and Targets Market Drivers
Figure 19. Synthetic Lethality-based Drugs and Targets Market Restraints
Figure 20. Synthetic Lethality-based Drugs and Targets Market Trends
Figure 21. AbbVie Recent Developments and Future Plans
Figure 22. AstraZeneca Recent Developments and Future Plans
Figure 23. BeiGene Recent Developments and Future Plans
Figure 24. Clovis Oncology Recent Developments and Future Plans
Figure 25. GlaxoSmithKline Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. AtlasMedx Recent Developments and Future Plans
Figure 28. Chordia Therapeutics Recent Developments and Future Plans
Figure 29. IDEAYA Biosciences Recent Developments and Future Plans
Figure 30. Mission Therapeutics Recent Developments and Future Plans
Figure 31. Repare Therapeutics Recent Developments and Future Plans
Figure 32. Sierra Oncology Recent Developments and Future Plans
Figure 33. SyntheX Labs Recent Developments and Future Plans
Figure 34. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players in 2021
Figure 35. Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Synthetic Lethality-based Drugs and Targets Revenue Market Share in 2021
Figure 37. Global Top 10 Players Synthetic Lethality-based Drugs and Targets Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Type in 2021
Figure 40. Global Synthetic Lethality-based Drugs and Targets Market Share Forecast by Type (2023-2028)
Figure 41. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application in 2021
Figure 42. Global Synthetic Lethality-based Drugs and Targets Market Share Forecast by Application (2023-2028)
Figure 43. North America Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 44. North America Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 45. North America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Country (2017-2028)
Figure 46. United States Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 50. Europe Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 51. Europe Synthetic Lethality-based Drugs and Targets Revenue Market Share by Country (2017-2028)
Figure 52. Germany Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue Market Share by Region (2017-2028)
Figure 60. China Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 67. South America Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 68. South America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Figure 1. Synthetic Lethality-based Drugs and Targets Picture
Figure 2. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type in 2021
Figure 3. Monotherapy
Figure 4. Combination Therapy
Figure 5. Synthetic Lethality-based Drugs and Targets Revenue Market Share by Application in 2021
Figure 6. Medical Research Institution Picture
Figure 7. Hospital and Clinic Picture
Figure 8. Other Picture
Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Synthetic Lethality-based Drugs and Targets Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Region (2017-2028)
Figure 12. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Region in 2021
Figure 13. North America Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Synthetic Lethality-based Drugs and Targets Market Drivers
Figure 19. Synthetic Lethality-based Drugs and Targets Market Restraints
Figure 20. Synthetic Lethality-based Drugs and Targets Market Trends
Figure 21. AbbVie Recent Developments and Future Plans
Figure 22. AstraZeneca Recent Developments and Future Plans
Figure 23. BeiGene Recent Developments and Future Plans
Figure 24. Clovis Oncology Recent Developments and Future Plans
Figure 25. GlaxoSmithKline Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. AtlasMedx Recent Developments and Future Plans
Figure 28. Chordia Therapeutics Recent Developments and Future Plans
Figure 29. IDEAYA Biosciences Recent Developments and Future Plans
Figure 30. Mission Therapeutics Recent Developments and Future Plans
Figure 31. Repare Therapeutics Recent Developments and Future Plans
Figure 32. Sierra Oncology Recent Developments and Future Plans
Figure 33. SyntheX Labs Recent Developments and Future Plans
Figure 34. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players in 2021
Figure 35. Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Synthetic Lethality-based Drugs and Targets Revenue Market Share in 2021
Figure 37. Global Top 10 Players Synthetic Lethality-based Drugs and Targets Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Type in 2021
Figure 40. Global Synthetic Lethality-based Drugs and Targets Market Share Forecast by Type (2023-2028)
Figure 41. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application in 2021
Figure 42. Global Synthetic Lethality-based Drugs and Targets Market Share Forecast by Application (2023-2028)
Figure 43. North America Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 44. North America Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 45. North America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Country (2017-2028)
Figure 46. United States Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 50. Europe Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 51. Europe Synthetic Lethality-based Drugs and Targets Revenue Market Share by Country (2017-2028)
Figure 52. Germany Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Synthetic Lethality-based Drugs and Targets Revenue Market Share by Region (2017-2028)
Figure 60. China Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 67. South America Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 68. South America Synthetic Lethality-based Drugs and Targets Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Synthetic Lethality-based Drugs and Targets Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Synthetic Lethality-based Drugs and Targets Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Synthetic Lethality-based Drugs and Targets Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Synthetic Lethality-based Drugs and Targets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
